SpaceX Staggered Lockup: How It Works and Full Calendar
SpaceX's IPO lockup is unusually complex, with multiple tranches spread over 18 months. The first major unlock on August 6, 2026, alone exceeds the entire original float, setting up a test of investor appetite.
By Stratton Journal Research

SpaceX's post-IPO share lockup is not the typical single 180-day cliff. Instead, the company structured a multi-tranche release that staggers eligibility over more than a year, with the largest single block tied to Elon Musk's holdings unlocking only in mid-2027. The design reduces the risk of a one-day flood, but it still creates repeated supply events that investors will need to navigate.
How the Staggered Lockup Works
The lockup applies to most employees and many early institutional holders. Their shares become eligible in stages, tied to both earnings dates and fixed calendar milestones. The first major tranche unlocks on August 6, 2026, the second trading day after Q2 earnings, releasing roughly 911.5 million shares. That is about 20% of the eligible pool and is larger than the entire original IPO float of approximately 555 to 640 million shares.
Subsequent fixed-date tranches follow at days 70, 90, 105, 120, and 135 post-IPO, each releasing around 319 to 328 million shares. A larger tranche of about 1.3 billion shares unlocks after Q3 earnings in late October or early November 2026. The final residual unlock for this group occurs on December 8, 2026, day 180.
There is also a price-contingent extra tranche of 10% that would have unlocked after Q2 earnings if the stock had closed at or above $175.50 for 5 of any 10 consecutive trading days before the first earnings release. That condition was not met, so this tranche remains locked.
Extended Lockup and Musk's Shares
A separate group of larger, longer-term holders has a schedule that extends into 2027, with additional releases after Q4 2026, Q1 2027, and Q2 2027 earnings, plus fixed-date releases around March 18, May 17, and June 12, 2027.
Elon Musk's shares, approximately 6.4 billion including Class B and options-related holdings, are subject to a strict 366-day lockup with no early-release provisions. They become eligible around June 12, 2027. This is by far the largest single block and represents a significant overhang for the stock well into next year.
Why the Structure Matters
The staggered design avoids the single massive cliff that has historically pressured many IPO stocks. But it does not eliminate supply pressure. Instead, it spreads it out, creating a series of unlock events through the second half of 2026. The market is already pricing in these events, but the sheer size of the August 6 tranche, larger than the original float, makes it the most closely watched near-term catalyst.
Investors should note that unlock eligibility does not mean immediate selling. Actual sales are voluntary and may be limited by Rule 144 volume restrictions for affiliates, company blackout windows, and individual decisions. The share counts are the maximum amounts that could be sold, not predictions of actual selling.
Risks and Uncertainties
The main risk is that the repeated supply events depress the stock price, particularly if demand does not keep pace. The August 6 unlock alone could add significant selling pressure. On the other hand, if the company's fundamentals remain strong and the market absorbs the supply, the staggered structure could prove less disruptive than a single cliff.
There is also uncertainty around the exact timing of earnings-tied releases, which depend on the actual earnings calendar. Share counts are approximate and could shift slightly with final calculations. The price-contingent tranche not being met removes one potential source of supply, but the remaining schedule is still substantial.
Bottom Line
SpaceX's lockup is a complex, multi-stage process that will unfold over the next year. The first major test comes on August 6, 2026, when a tranche larger than the original float becomes eligible. How the market absorbs that supply will set the tone for subsequent unlocks. Investors should monitor trading volumes and price action around each event, and recognize that the largest overhang, Musk's shares, remains far in the future.
Further research
- Palantir's Q2 2026 Blowout: AI Monetization, Margin Expansion, and the Valuation Question
- SpaceX's 99% Cost-to-Orbit Target: Starship Reusability Progress and What It Means for Investors
- Elevated Short Interest After an Earnings Beat: Why It Doesn't Always Trigger a Squeeze
- SpaceX's $18.4 Billion Capex Shock: AI Infrastructure Spending Outpaces Consensus
Sources
Related research
Palantir's Q2 2026 Blowout: AI Monetization, Margin Expansion, and the Valuation Question
Palantir's Q2 2026 results show 93% revenue growth, a 47% operating margin, and a raised outlook. But with the stock up 30% and trading at a forward P/E of 60, investors must weigh the AI tailwinds against a demanding valuation.
SpaceX's 99% Cost-to-Orbit Target: Starship Reusability Progress and What It Means for Investors
SpaceX reiterated a transformative cost target for Starship: a 99% reduction in cost to orbit versus historical averages. Recent flight tests, including an intact heat shield, suggest the company is closer to full and rapid reusability, but significant technical and regulatory hurdles remain.
Elevated Short Interest After an Earnings Beat: Why It Doesn't Always Trigger a Squeeze
A strong earnings beat can be a catalyst for short covering, but as SpaceX's recent report shows, elevated short interest doesn't guarantee a rally. The market's focus on other metrics, like heavy capex, can override the positive news.
SpaceX's $18.4 Billion Capex Shock: AI Infrastructure Spending Outpaces Consensus
SpaceX reported Q2 2026 capex of $18.4 billion, six times higher than a year ago, driven by $15.8 billion in AI infrastructure. Despite a revenue beat, shares fell as investors weighed the scale of spending against near-term profitability.
Disclaimer
This content is for educational and informational purposes only. It is not financial advice. Stratton Journal does not recommend any specific investment or trading strategy.


